Status:
COMPLETED
NBI in Oral Cavity Cancer
Lead Sponsor:
Region Örebro County
Conditions:
Oral Cancer
Eligibility:
All Genders
18+ years
Brief Summary
Oral cancer starts in the mucosa of the mouth and the most common site is the tongue and gingiva. One of the most important issues for the prognosis is to surgically remove all the cancer, at the side...
Detailed Description
Patients with primary oral cavity cancer will be examined with Narrow Band Imaging (NBI) at the time of surgery. Olympus® equipment will be used together with straight 5,9 mm endoscopes. First the tu...
Eligibility Criteria
Inclusion
- Biopsy proven squamous cell carcinomaI. International Statistical Classification of Diseases and Related Health Problems (ICD) 10 C02-C06.
Exclusion
- former extensive surgery in the oral cavity that effects the examination
- former radiation to the oral cavity
- patients not suitable for surgery
Key Trial Info
Start Date :
August 13 2020
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
March 12 2024
Estimated Enrollment :
49 Patients enrolled
Trial Details
Trial ID
NCT04398121
Start Date
August 13 2020
End Date
March 12 2024
Last Update
May 3 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Örebro University Hospital
Örebro, Sweden, 70185